Untitled
Co-Morbidities and Adverse Drug Reactions in HIV
Abstract categories

2021 abstract categories

***ABSTRACT SUBMISSION HAS NOW CLOSED.
ABSTRACTS RECEIVED NOW CANNOT BE ACCEPTED***

Abstracts, which may address clinical, epidemiological as well as aspects concerning pathogenesis will be considered in the following categories,
now also including COVID-19:

  Adipocyte biology, insulin resistance
  and lipid metabolism

  Clinical management of ADRs

  Aging, frailty, disability &
  senescence
  COVID and comorbidities
  Body composition and weight change   Liver disease (incl. viral hepatitis-related), hepatotoxicity
  Bone metabolism & toxicities  Other non-infectious comorbidities (incl. cancer, mental health, neurocognitive disorders and renal toxicities)
  Cardiovascular disease   Pulmonary Disease

A limited number of free registrations are available - for further information please visit the Registration page

Accepted abstracts are selected for either Oral or Poster presentation, at the discretion of the Organizing Committee. 

All accepted abstracts will be published in the peer-reviewed journal, Antiviral Therapy.

The final abstract abstract submission deadline was Thursday 21 October. Abstracts submitted after this date cannot be accepted.

 

 

 

 

Please submit your abstracts here